Developing National Systemic Anti-Cancer Therapy (SACT) reporting

Those delivering cancer services are more engaged with analysis from data, and better able to use this information to improve clinical care

NHS SACT dashboard users can see the usability of the dashboard and the relevance of comparative SACT analysis.

The SCRIS team gave demonstrations of the prototype SACT dashboard to each of the regional cancer networks in Scotland, to raise awareness and seek feedback for improvements.

Attended by a wide range of health board staff, these half-day drop-in sessions walked consultants, lead nurses, service managers and others through the content, form and function of the prototype SACT dashboard. Attendees were struck by the versatility, scope and utility of the dashboard.

SACT dashboard demonstration attendee comments included:

A national view of SACT treatment can inform understanding and planning at local, regional and national level.

National SACT reports will be created for the first time to address five initial agreed priorities:

1. 30-day mortality
2. Common regimes
3. SACT treatment outside Home Board
4. Duration of therapy
5. Pattern of practice (inpatient/outpatient/day case split)

A national view can identify gaps in data quality and completeness.

Developing the SACT dashboard in a user-led way, and interrogating the data with multiple stakeholders, has surfaced gaps in knowledge which can now be addressed. For example, it became apparent that community prescribing data was being captured manually and not entered onto CEPAS and so expenditure on SACT at community levels was not visible across Health Boards.